McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D. is quoted in an April 1, 2019 BioPharm International article entitled, “Predictability Improves Prospects for Biopharma Patent Holders.” Protecting biopharmaceutical patents has always been challenging, especially in the United States, birthplace of the biotech industry. View the article
